Press Releases
Recipharm invests USD 2.5 million in clinical GMP capacity for active pharmaceutical ingredients
Global contract development and manufacturing organisation (CDMO), Recipharm, has announced an investment and capacity expansion at its facility in Israel. This investment will support...
News
Allergy Alarm Raised On Pfizer-BioNTech COVID-19 Vaccine
02 NHS Workers have reportedly suffered from allergic reactions from the first jab of Pfizer-BioNtech COVID-19 vaccine in the UK.
MHRA has issued...
News
For Airlines, Dry Ice in Vaccine Transport Demands Special Attention
The large amounts of dry ice needed to speed Covid-19 vaccine candidates to pandemic-weary populations will call for special attention from airlines and safety...
News
LabCorp (LH) Covance Arms Shows Momentum Amid COVID-19 Woes
The ongoing synergy from the Covance consolidation is a major plus. However, a challenging volume environment for testing laboratories and softness in utilization are...
News
COVID-19 vaccine: After Pfizer, SII, Bharat Biotech seeks emergency use authorisation for its Covaxin
Bharat Biotech had applied to the Drugs Controller General of India seeking emergency use authorisation for its Covid-19 vaccine Covaxin. The Pune-based Serum Institute...
News
Sheremetyevo International handles Sputnik V vaccine shipment
Sheremetyevo International Airport was the launching point for an early batch of Russian Covid-19 vaccine Sputnik V. In total, 20 doses of the vaccine...
Clinical Trials
Lilly’s tirzepatide significantly reduced A1C and body weight in people with type 2 diabetes
Tirzepatide led to superior A1C and body weight reductions from baseline in adults with type 2 diabetes after 40 weeks of treatment in topline...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read